scispace - formally typeset
R

Richard Wagland

Researcher at University of Southampton

Publications -  80
Citations -  1426

Richard Wagland is an academic researcher from University of Southampton. The author has contributed to research in topics: Population & Quality of life (healthcare). The author has an hindex of 20, co-authored 76 publications receiving 1039 citations. Previous affiliations of Richard Wagland include RMIT University.

Papers
More filters
Journal ArticleDOI

The ENABLE study protocol: Understanding and characterising the value and role of self-management support for people living with cancer that is treatable but not curable

TL;DR: Qualitative longitudinal methods will examine how support needs change over time in relation to self-management and unpredictable disease trajectories, producing evidence to inform service innovation for those living with treatable but incurable cancer.
Journal ArticleDOI

Experiences of Support for Sexual Dysfunction in Men With Prostate Cancer: Findings From a U.K.-Wide Mixed Methods Study

TL;DR: Watson et al. as discussed by the authors explored men's experiences of support for sexual dysfunction following prostate cancer diagnosis, and found that the most commonly offered intervention was medication and 39.3% of those who tried medication found this helpful.
Book Chapter

The impact of the POPP programme on changes in individual service use

TL;DR: The ‘Partnership for Older People’s Project’ (POPP) programme was funded by the Department of Health to create a sustainable shift in the care of older people, moving away from a focus on institutional and hospital based crisis care, toward earlier and better targeted interventions within community third sector, social and health care settings.
Journal ArticleDOI

Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.

TL;DR: Prostate cancer survivors presenting symptomatically report poorer functional outcomes than PSA-detected survivors, and Clinicians should be aware that men presenting with symptoms are more likely to report functional difficulties after prostate cancer treatment and may need additional aftercare if these difficulties persist.